Best Practice & Research Clinical Rheumatology
Volume 20, Issue 4 , Pages 653-672 , August 2006

Acute polyarthritis

  • Kathryn Dao, MD

      Affiliations

    • Corresponding Author InformationCorresponding author. Address: Rheumatology and Clinical Immunology Division, Presbyterian Hospital of Dallas, 8200 Walnut Hill, Dallas, TX 75231, USA. Tel.: +1 214 345 7376; Fax: +1 214 345 7999.
  • ,
  • John J. Cush, MD

References 

  1. Centers for Disease Control and Prevention . Prevalence of self-reported arthritis or chronic joint symptoms among adults, United States 2001. MMWR. 2002;51:948–950
  2. Centers for Disease Control and Prevention . Public health and aging: projected prevalence of self-reported arthritis or chronic joint symptoms among persons aged >65 years – United States, 2005–2030. MMWR. 2003;52:489–491
  3. Centers for Disease Control and Prevention . Adults who have never seen a health-care provider for chronic joint symptoms – United States, 2001. MMWR. 2003;52:416–419
  4. Centers for Disease Control and Prevention . Direct and indirect costs of arthritis and other rheumatic conditions – United States, 1997. MMWR. 2003;52:1124–1127
  5. Uhlig T, Kvien TK, Glennas A, et al. The incidence and severity of rheumatoid arthritis, results from a county register in Oslo, Norway. The Journal of Rheumatology. 1998;25:1078–1084
  6. Symmons DP, Barrett EM, Bankhead CR, et al. The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. British Journal of Rheumatology. 1994;33:735–739
  7. Doran MF, Pond GR, Crowson CS, et al. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis and Rheumatism. 2002;46:625–631
  8. Pincus T. Rheumatoid arthritis: a medical emergency?. Scandinavian Journal of Rheumatology. 1994;23(supplement 100):21–30
  9. Moreland LW, Bridges SL. Early rheumatoid arthritis: a medical emergency?. The American Journal of Medicine. 2001;111:498–500
  10. Weinblatt ME. Rheumatoid arthritis: treat now, not later!. Annals of Internal Medicine. 1996;124:773–774
  11. Irvine S, Munro R, Porter D. Early referral, diagnosis, and treatment of rheumatoid arthritis: evidence for changing medical practice. Annals of the Rheumatic Diseases. 1999;58:510–513
  12. Chan KW, Felson DT, Yood RA, Walker AM. The lag time between onset of symptoms and diagnosis of rheumatoid arthritis. Arthritis and Rheumatism. 1994;37:814–820
  13. Hernandez-Garcia C, Vargas E, Abasolo L, et al. Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis. The Journal of Rheumatology. 2000;27:2323–2328
  14. Van Zeben D, Hazes JMW, Zwinderman AH, Vandenbroucke JP. The severity of rheumatoid arthritis: a 6-year followup study of younger women with symptoms of recent onset. The Journal of Rheumatology. 1994;21:1620–1625
  15. Wolfe F, Ross K, Hawley DJ, et al. The prognosis of rheumatoid arthritis and undifferentiated polyarthritis syndrome in the clinic: a study of 1141 patients. The Journal of Rheumatology. 1993;20:2005–2009
  16. Tunn EJ, Bacon PA. Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic. British Journal of Rheumatology. 1993;32:97–103
  17. Bathon JM, Martin RW, Fleischmann RM, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. The New England Journal of Medicine. 2000;343:1586–1593
  18. St Clair EW, van der Heijde DM, Smolen JS, et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis and Rheumatism. 2004;50:3432–3443
  19. Breedveld FC, Kavanaugh AF, Cohen SB, et al. Early treatment of rheumatoid arthritis (RA) with adalimumab (Humira) plus methotrexate vs. adalimumab alone or methotrexate alone: the PREMIER Study. Arthritis and Rheumatism. 2004;50(supplement):L5
  20. Nell VP, Machold KP, Eberl G, et al. Benefit of very early referral and very early therapy with disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis. Rheumatology. 2004;43:819–820
  21. Peltomaa R, Paimela L, Helve T, Leirisalo-Repo M. Effect of treatment on the outcome of very early rheumatoid arthritis. Scandinavian Journal of Rheumatology. 2001;30:143–148
  22. Lard LR, Visser H, Speyer I, et al. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. The American Journal of Medicine. 2001;111:498–500
  23. Mottenen T, Hannonen P, Korpela M, et al. Delay to institution of therapy and induction of remission using single-drug or combination disease modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis and Rheumatism. 2002;46:894–898
  24. Symmons DPM, Hazes JMW, Silman AJ. Cases of early inflammatory polyarthritis should not be classified as having rheumatoid arthritis. The Journal of Rheumatology. 2003;30:902–904
  25. Arnett FC, Edworth SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism. 1988;31:315–324
  26. Saraux A, Berthelot JM, Chales G, et al. Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis and Rheumatism. 2001;44:2485–2491
  27. Harris E. Clinical features of rheumatoid arthritis. In:  Harris E,  Budd RC,  Firestein GS, et al. editor. Kelley's Textbook of Rheumatology. Philadelphia: Elsevier Saunders; 2005;p. 1043–1078
  28. Van Der Horst-Bruinsma IE, Speyer I, Visser H, et al. Diagnosis and course of early-onset arthritis: results of a special early arthritis clinic compared to routine patient care. British Journal of Rheumatology. 1998;37:1084–1088
  29. Visser H, Cessie S, Vos K, et al. How to diagnose rheumatoid arthritis early. A prediction model for persistent erosive arthritis. Arthritis and Rheumatism. 2002;46:357–365
  30. Jansen LM, Schaardenburg D, van der Horst-Bruinsma IE, Dijkmans BA. One year outcome of undifferentiated polyarthritis. Annals of the Rheumatic Diseases. 2002;61:700–703
  31. Green M, Marzo-Ortega H, McGonagle D, et al. Persistence of mild early inflammatory arthritis: the importance of disease duration, rheumatoid factor, and the shared epitope. Arthritis and Rheumatism. 1999;42:2184–2188
  32. Visser H. Early diagnosis of rheumatoid arthritis. Best Practice & Research. Clinical Rheumatology. 2005;19:55–72
  33. Stockman A, Tait BD, Wolfe R, et al. Clinical, laboratory and genetic markers associated with erosions and remission in patients with early inflammatory arthritis: a prospective cohort study. Rheumatology International. 2005;7:1–10
  34. Harrison BJ, Symmons DPM, Brennan P, et al. Natural remission in inflammatory polyarthritis: issues of definition and prediction. British Journal of Rheumatology. 1996;35:1096–1100
  35. Grassi W. Clinical evaluation versus ultrasonography: who is the winner?. The Journal of Rheumatology. 2003;30:908–909
  36. Pando JA, Duray P, Yarboro C, et al. Synovitis occurs in some clinically normal and asymptomatic joints in patients with early arthritis. The Journal of Rheumatology. 2000;27:1848–1854
  37. Szkudlarek M, Court-Payen , Jacobsen S, et al. Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis. Arthritis and Rheumatism. 2003;48:955–962
  38. Ostergaard M, Szkudlarek M. Imaging in rheumatoid arthritis – why MRI and ultrasonography can no longer be ignored. Scandinavian Journal of Rheumatology. 2003;32:63–73
  39. Szkudlarek M, Narvestad E, Klarlund M, et al. Ultrasonography of metatarsophalangeal joints in rheumatoid arthritis: comparison with magnetic resonance imaging, conventional radiography, and clinical examination. Arthritis and Rheumatism. 2004;50:2103–2112
  40. Gormley G, Steele K, Gilliland D, et al. Can rheumatologists agree on a diagnosis of inflammatory arthritis in an early synovitis clinic?. Annals of the Rheumatic Diseases. 2001;60:638–639
  41. Quinn MA, Green MJ, Conaghan P, Emery P. How do you diagnose rheumatoid arthritis early?. Best Practice & Research. Clinical Rheumatology. 2001;15:49–66
  42. Fleming A, Dodman S, Crown JM, Corbett M. Extraarticular features in early rheumatoid disease. BMJ. 1976;1:1241–1243
  43. Combe B, Dougados M, Goupille P, et al. Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study. Arthritis and Rheumatism. 2001;44:1736–1743
  44. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. The New England Journal of Medicine. 2003;349:1526–1533
  45. Aho K, Heliovaara M, Maatela J, et al. Rheumatoid factors antedating clinical rheumatoid arthritis. The Journal of Rheumatology. 1991;18:1282–1284
  46. Firestein GS. Clinical features of rheumatoid arthritis. In:  Harris E,  Budd RC,  Firestein GS, et al. editor. Kelley's Textbook of Rheumatology. Philadelphia: Elsevier Saunders; 2005;p. 996–1042
  47. Verbruggen G, De Backer S, Deforce D, et al. X linked agammaglobulinaemia and rheumatoid arthritis. Annals of the Rheumatic Diseases. 2005;64:1075–1078
  48. Fu JL, Shyur SD, Lin HY, Lai YC. X-linked agammaglobulinemia presenting as juvenile chronic arthritis: report of one case. Acta Paediatrica Taiwanica. 1999;40:280–283
  49. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factors predict the development of rheumatoid arthritis. Arthritis and Rheumatism. 2003;48:2741–2749
  50. Lunt M, Symmons DPM, Silman AJ. An evaluation of the decision tree format of the American College of Rheumatology 1987 classification criteria for rheumatoid arthritis. Arthritis and Rheumatism. 2005;52:2227–2283
  51. Jansen LM, van der Horst-Bruinsma IE, Schaardenburg D, et al. Predictors of radiographic joint damage in patients with early rheumatoid arthritis. Annals of the Rheumatic Diseases. 2001;60:924–927
  52. Hulsemann JL, Zeidler H. Undifferentiated arthritis in an early synovitis out-patient clinic. Clinical and Experimental Rheumatology. 1995;13:37–43
  53. Nell VP, Machold KP, Stamm TA, et al. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Annals of the Rheumatic Diseases. 2005;64:1731–1736
  54. Cordonnier C, Meyer O, Palazzo E, et al. Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: comparison with rheumatoid factor. British Journal of Rheumatology. 1996;35:620–624
  55. Hassfeld W, Steiner G, Graninger W, et al. Autoantibody to the nuclear antigen RA33: a marker for early rheumatoid arthritis. British Journal of Rheumatology. 1993;32:199–203
  56. Kim JM, Weisman MH. When does rheumatoid arthritis begin and why do we need to know?. Arthritis and Rheumatism. 2000;43:473–484
  57. Raza K, Breese M, Nightingale P, et al. Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis. The Journal of Rheumatology. 2005;32:231–238
  58. Sokka T, Willoughby J, Yazici Y, Pincus T. Databases of patients with early rheumatoid arthritis in the USA. Clinical and Experimental Rheumatology. 2003;21(supplement 31):S146–S153
  59. Paulus HE, Wiesner J, Bulpitt KJ, et al. Autoantibodies in early seropositive rheumatoid arthritis, before and during disease modifying antirheumatic drug treatment. The Journal of Rheumatology. 2002;29:2513–2520
  60. Meyer O, Combe B, Elias A, et al. Autoantibodies predicting the outcome of rheumatoid arthritis: evaluation in two subsets of patients according to severity of radiographic damage. Annals of the Rheumatic Diseases. 1997;56:682–685
  61. Goronzy JJ, Matteson EL, Fulbright JW, et al. Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis and Rheumatism. 2004;50:43–54
  62. Brennan P, Harrison B, Barrett E, et al. A simple algorithm to predict the development of radiological erosions in patients with early rheumatoid arthritis: prospective cohort study. BMJ. 1996;313:471–476
  63. McCune JW, Golbus J. Mono-articular arthritis. In:  Harris E,  Budd RC,  Firestein GS, et al. editor. Kelley's Textbook of Rheumatology. Philadelphia: Elsevier Saunders; 2005;p. 501–513
  64. Weitoft T, Uddenfeldt P. Importance of synovial fluid aspiration when injecting intra-articular corticosteroids. Annals of the Rheumatic Diseases. 2000;59:233–235
  65. Green M, Marzo-Ortega H, Wakefield RJ, et al. Predictors of outcome in patients with oligoarthritis: results of a protocol of intraarticular corticosteroids to all clinically active joints. Arthritis and Rheumatism. 2001;44:1177–1183
  66. Clarke AF, St-Pierre Y, Joseph L, et al. Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs. The Journal of Rheumatology. 2001;28:2416–2424
  67. Puolakka K, Kautiainen H, Pekurinen M, et al. Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients' sickness absence and gross income: experience from the FIN-RACo Trial. Annals of the Rheumatic Diseases. 2006;65:899–904
  68. Fex E, Jonsson K, Johnson U, Eberhardt K. Development of radiographic damage during the first 5–6 yr of rheumatoid arthritis. A prospective follow-up study of a Swedish cohort. British Journal of Rheumatology. 1996;35:1106–1115
  69. Hoving JL, Buchbinder R, Hall S, et al. A comparison of magnetic resonance imaging, sonography, and radiography of the hand in patients with early rheumatoid arthritis. The Journal of Rheumatology. 2004;31:663–675
  70. Szkudlarek M, Narvestad E, Klarlund M, et al. Ultrasonography of the metatarsophalangeal joints in rheumatoid arthritis: comparison with magnetic resonance imaging, conventional radiography, and clinical examination. Arthritis and Rheumatism. 2004;50:2103–2112
  71. Magnani M, Salizzoni E, Mule R, et al. Ultrasonography detection of early bone erosions in the metacarpophalangeal joints of patients with rheumatoid arthritis. Clinical and Experimental Rheumatology. 2004;22:743–748
  72. Boers M, Verhoeven AC, Markusse HM, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet. 1997;350:309–318
  73. Egamose C, Lund B, Borg G, et al. Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study. The Journal of Rheumatology. 1995;22:2208–2213
  74. Verstappen SM, Jacobs JW, Bijlsma JW. Utrecht Rheumatoid Arthritis Study Group. The Utrecht experience with different treatment strategies in early rheumatoid arthritis. Clinical and Experimental Rheumatology. 2003;21(supplement 31):S165–S168
  75. Alarcon GS. Epidemiology of rheumatoid arthritis. Rheumatic Diseases Clinics of North America. 1995;21:589–604
  76. Cush JJ, Kavanaugh A. Rheumatoid Arthritis: Early Diagnosis and Treatment. West Islip, NY: Professional Communications, Inc; 2005;pp. 203–207
  77. Lipsky P. Algorithms for the diagnosis and management of musculoskeletal complaints. The American Journal of Medicine. 1997;103:62S
  78. Machold KP, Nell VP, Stamm TA, et al. The Austrian early arthritis registry. Clinical and Experimental Rheumatology. 2003;21(supplement 31):S113–S117
  79. Speyer I, Hazes JM, Breedveld FC. Recruitment of patients with early RA – The Netherlands experience. The Journal of Rheumatology. 1996;44(supplement):84–85
  80. Morel J, Legouffe MC, Bozonat MC, et al. Outcomes in patients with incipient undifferentiated arthritis. Joint Bone Spine. 2000;67:49–53
  81. Nissila M, Isomaki H, Kaarela K, et al. Prognosis of inflammatory joint diseases. A three year followup study. Scandinavian Journal of Rheumatology. 1983;12:33–38

PII: S1521-6942(06)00055-6

doi: 10.1016/j.berh.2006.05.007

Best Practice & Research Clinical Rheumatology
Volume 20, Issue 4 , Pages 653-672 , August 2006